semaglutide addiction clinical trials Could GLP-1 medications help transform treatment for alcohol addiction? Alcohol Use Disorder affects millions, yet there haven't been any new medications approved to treat it in 20 years. Now, new #CUAnschutz research Once-Weekly Semaglutide in Adults with

Novo Nordisks launch of the first oral GLP-1 for obesity brings Wegovy to U.S

Semaglutide : FDA-approved since 2017 for T2D, 2021 for obesity

Patients were additionally required to have 1 of the following based on data from the 1-year baseline period or the index date: 1 International Classification of Diseases, Tenth Revision (ICD-10) diagnosis code or electronic medical record indicating overweight (BMI of 2529.9 kg/m) with 1 obesity-related complication (identified through ICD-10 diagnosis codes) or 1 ICD-10 diagnosis code or electronic medical record indicating obesity (BMI 30 kg/m 2

However, alcohol might also make depression worse in some cases

It also protects the skin from oxidative stress, boosts skin health, and promotes a clearer complexion